Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021.

Mallon PW; Mary Horgan; McAloon CG; Lunn PD; J Little; A Beck; A Bennett; N Shaver; A Conway; R O'Regan; B Whelan; Rapid Testing Expert Advisory Group; Members of the Rapid Testing Expert Advisory Group

doi:10.2807/1560-7917.es.2022.27.3.2101202

Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021.

Mallon PW
, Mary Horgan
, McAloon CG
, Lunn PD
, J Little
, A Beck
, A Bennett
, N Shaver
, A Conway
, R O'Regan
, B Whelan
, Rapid Testing Expert Advisory Group
, Members of the Rapid Testing Expert Advisory Group

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

3 Citations (Scopus)

Original language	Undefined/Unknown
Journal	Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
DOIs	https://doi.org/10.2807/1560-7917.es.2022.27.3.2101202
Publication status	Published - Jan 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.2807/1560-7917.es.2022.27.3.2101202

Cite this

PW, M., Horgan, M., CG, M., PD, L., Little, J., Beck, A., Bennett, A., Shaver, N., Conway, A., O'Regan, R., Whelan, B., Group, R. T. E. A., & Group, M. O. T. R. T. E. A. (2022). Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. https://doi.org/10.2807/1560-7917.es.2022.27.3.2101202

@article{564675775b4247488501e4a0309f0db9,

title = "Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021.",

author = "Mallon PW and Mary Horgan and McAloon CG and Lunn PD and J Little and A Beck and A Bennett and N Shaver and A Conway and R O'Regan and B Whelan and Group, \{Rapid Testing Expert Advisory\} and Group, \{Members of the Rapid Testing Expert Advisory\}",

year = "2022",

month = jan,

doi = "10.2807/1560-7917.es.2022.27.3.2101202",

language = "Undefined/Unknown",

journal = "Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin",

}

PW, M, Horgan, M, CG, M, PD, L, Little, J, Beck, A, Bennett, A, Shaver, N, Conway, A, O'Regan, R, Whelan, B, Group, RTEA & Group, MOTRTEA 2022, 'Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021.', Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. https://doi.org/10.2807/1560-7917.es.2022.27.3.2101202

Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021. / PW, Mallon; Horgan, Mary; CG, McAloon et al.
In: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 01.2022.

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

TY - JOUR

T1 - Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021.

AU - PW, Mallon

AU - Horgan, Mary

AU - CG, McAloon

AU - PD, Lunn

AU - Little, J

AU - Beck, A

AU - Bennett, A

AU - Shaver, N

AU - Conway, A

AU - O'Regan, R

AU - Whelan, B

AU - Group, Rapid Testing Expert Advisory

AU - Group, Members of the Rapid Testing Expert Advisory

PY - 2022/1

Y1 - 2022/1

UR - http://europepmc.org/abstract/med/35057900

U2 - 10.2807/1560-7917.es.2022.27.3.2101202

DO - 10.2807/1560-7917.es.2022.27.3.2101202

M3 - Article

C2 - 35057900

JO - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

JF - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

ER -

PW M, Horgan M, CG M, PD L, Little J, Beck A et al. Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2022 Jan. doi: 10.2807/1560-7917.es.2022.27.3.2101202

Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021.

UN SDGs

Access to Document

Other files and links

Cite this